These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34142239)

  • 21. Kinetics of oral colonization by Candida spp. during topical corticotherapy for oral lichen planus.
    Pereira Tdos S; Silva Alves Jde F; Gomes CC; Rocha do Nascimento A; Stoianoff MA; Gomez RS
    J Oral Pathol Med; 2014 Sep; 43(8):570-5. PubMed ID: 25320748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of oral candidiasis with oral lichen planus in patients using corticosteroid therapy - Meta-analysis.
    Alqahtani SS; Alabeedi FM
    J Popul Ther Clin Pharmacol; 2023; 30(1):e1-e13. PubMed ID: 36631413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phospholipase, esterase and hemolytic activities of Candida spp. isolated from onychomycosis and oral lichen planus lesions.
    Pakshir K; Zomorodian K; Karamitalab M; Jafari M; Taraz H; Ebrahimi H
    J Mycol Med; 2013 Jun; 23(2):113-8. PubMed ID: 23706304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid and unequivocal differentiation of Candida dubliniensis from other Candida species using species-specific DNA probes: comparison with phenotypic identification methods.
    Ellepola AN; Hurst SF; Elie CM; Morrison CJ
    Oral Microbiol Immunol; 2003 Dec; 18(6):379-88. PubMed ID: 14622344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Candida spp., xerostomia, and hyposalivation in oral lichen planus--a controlled study.
    Artico G; Freitas RS; Santos Filho AM; Benard G; Romiti R; Migliari DA
    Oral Dis; 2014 Apr; 20(3):e36-41. PubMed ID: 23656547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
    Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
    J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
    Arastehfar A; Yazdanpanah S; Bakhtiari M; Fang W; Pan W; Mahmoudi S; Pakshir K; Daneshnia F; Boekhout T; Ilkit M; Perlin DS; Zomorodian K; Zand F
    Med Mycol; 2021 May; 59(5):422-430. PubMed ID: 32692816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.
    Taj-Aldeen SJ; Kolecka A; Boesten R; Alolaqi A; Almaslamani M; Chandra P; Meis JF; Boekhout T
    Infection; 2014 Apr; 42(2):393-404. PubMed ID: 24352810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypha essential genes in Candida albicans pathogenesis of oral lichen planus: an in-vitro study.
    He H; Wang Y; Fan Y; Li C; Han J
    BMC Oral Health; 2021 Dec; 21(1):614. PubMed ID: 34852796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adhesion to buccal epithelial cells of Candida albicans isolates from oral lichen planus].
    Zeng X; Chen QM; Nie MH; Li BQ
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2005 Dec; 23(6):537-8. PubMed ID: 16430191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Speciation of Candida using CHROMagar in cases with oral epithelial dysplasia and squamous cell carcinoma.
    Hulimane S; Maluvadi-Krishnappa R; Mulki S; Rai H; Dayakar A; Kabbinahalli M
    J Clin Exp Dent; 2018 Jul; 10(7):e657-e660. PubMed ID: 30057706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseases.
    Nagao Y; Hashimoto K; Sata M
    BMC Gastroenterol; 2012 Nov; 12():155. PubMed ID: 23122361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candida biotypes in patients with oral leukoplakia and lichen planus. Candida biotypes in leukoplakia and lichen planus.
    Lipperheide V; Quindós G; Jiménez Y; Pontón J; Bagán-Sebastián JV; Aguirre JM
    Mycopathologia; 1996; 134(2):75-82. PubMed ID: 8981773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced immune responses to purified protein derivative and Candida albicans in oral lichen planus.
    Simark-Mattsson C; Eklund C
    J Oral Pathol Med; 2013 Oct; 42(9):691-7. PubMed ID: 23607487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates.
    Junqueira JC; Fuchs BB; Muhammed M; Coleman JJ; Suleiman JM; Vilela SF; Costa AC; Rasteiro VM; Jorge AO; Mylonakis E
    BMC Microbiol; 2011 Nov; 11():247. PubMed ID: 22053894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of Candida albicans and non-albicans Candida species in oral candidiasis patients: Correlation between cell surface hydrophobicity and biofilm forming activities.
    Muadcheingka T; Tantivitayakul P
    Arch Oral Biol; 2015 Jun; 60(6):894-901. PubMed ID: 25819801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for non-albicans Candida and uncommon yeast isolates.
    Teke L; Barış A; Bayraktar B
    J Microbiol Methods; 2021 Jun; 185():106232. PubMed ID: 33961963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry to differentiate between Candida albicans and Candida dubliniensis.
    Roberts AL; Alelew A; Iwen PC
    Diagn Microbiol Infect Dis; 2016 May; 85(1):73-6. PubMed ID: 26971641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.